Respiratorius is a research company. Today, the company is mainly focused on development of new drug candidates for the treatment of chronic obstructive pulmonary disease (COPD), asthma and cancer. Additionally, the company focuses on project development in the area of cardiovascular diseases. The company was formed in 1999 as a spin-off from Lund University. The company is based in Lund.

Quotes for Respiratorius AB

Right Now

+/-
-0.07
%
-4,35%
Latest
1.54
High
1.605
Low
1.52
Volume
171 800
Turnover (SEK)
268 260
Value (MSEK)
242,0

Board

CEO

  • Johan Drott

Chairman Of The Board

  • Christer Fåhræus

Board

  • Anna Törner
  • Ingemar Kihlström
  • Kristina Drott
  • Olov Sterner
  • Sarah Fredriksson

Videos